GlassScriptPhysician profile
Solomon Korssa
NPI 1306298138
$1,216.98
in general payments reported to CMS, 2019-2025
15 companies · $170 in 2025
The $170 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $86.75 · 2022: $481 · 2023: $415 · 2024: $63.99 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $538 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $537.56 |
| Education | $111.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $332.37 | 2022-2025 | |
| Teva Pharmaceuticals USA, INC. | $212.99 | 2022-2023 | Austedo |
| Novo Nordisk INC | $144.56 | 2021-2023 | Ozempic, Rybelsus |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $113.40 | 2022-2025 | Caplyta |
| Exact Sciences Corporation | $101.21 | 2023-2025 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $70.44 | 2022-2023 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $39.05 | 2022-2025 | |
| Xeris Pharmaceuticals, INC. | $36.64 | 2022 | |
| Edwards Lifesciences Corporation | $32.93 | 2022 | |
| Lundbeck LLC | $31.65 | 2023 | Rexulti |
| Janssen Pharmaceuticals, INC | $30.53 | 2021-2022 | |
| Gilead Sciences, INC. | $26.14 | 2025 | |
| Supernus Pharmaceuticals, INC. | $16.00 | 2025 | Qelbree |
| Lilly USA, LLC | $15.07 | 2025 | Zepbound |
| Takeda Pharmaceuticals U.S.A., INC. | $14.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Solomon Korssa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.